Page last updated: 2024-09-04

salicylideneaniline and sb 202190

salicylideneaniline has been researched along with sb 202190 in 1 studies

Compound Research Comparison

Studies
(salicylideneaniline)
Trials
(salicylideneaniline)
Recent Studies (post-2010)
(salicylideneaniline)
Studies
(sb 202190)
Trials
(sb 202190)
Recent Studies (post-2010) (sb 202190)
230156510202

Protein Interaction Comparison

ProteinTaxonomysalicylideneaniline (IC50)sb 202190 (IC50)
Mitogen-activated protein kinase 13Homo sapiens (human)0.08
Bromodomain-containing protein 4Homo sapiens (human)2.95
TyrosinaseMus musculus (house mouse)0.03
Amine oxidase [flavin-containing] BRattus norvegicus (Norway rat)0.08
Casein kinase I isoform deltaHomo sapiens (human)0.188
Mitogen-activated protein kinase 12Homo sapiens (human)0.08
Mitogen-activated protein kinase 11Homo sapiens (human)0.1038
Mitogen-activated protein kinase 14Homo sapiens (human)0.0625
Tau-tubulin kinase 2Homo sapiens (human)9.34
large T antigenBetapolyomavirus macacae4.87

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Jung, SH; Manickam, M; Namasivayam, V; Pillaiyar, T1

Reviews

1 review(s) available for salicylideneaniline and sb 202190

ArticleYear
Inhibitors of Melanogenesis: An Updated Review.
    Journal of medicinal chemistry, 2018, 09-13, Volume: 61, Issue:17

    Topics: alpha-MSH; Biphenyl Compounds; Crystallization; Enzyme Inhibitors; Humans; Melanins; Monophenol Monooxygenase; Peptidomimetics; Radiation, Ionizing; Resveratrol; Signal Transduction; Skin

2018